Skip to search formSkip to main contentSkip to account menu

dupilumab

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Biologics for chronic rhinosinusitis with nasal polyps.
Review
2020
Review
2020
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents
During the past decade, significant therapeutic progress has been made in the field of allergic diseases, mainly concerning the… 
Highly Cited
2020
Highly Cited
2020
Real‐world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records
Clinical trial data for dupilumab, a monoclonal antibody against the interleukin‐4 receptor (IL‐4Rα), have shown that it is safe… 
Review
2019
Review
2019
Dupilumab use in dermatologic conditions beyond atopic dermatitis – a systematic review
Abstract Importance: While dupilumab has emerged as an effective treatment for moderate-to-severe atopic dermatitis (AD) since… 
Highly Cited
2019
Highly Cited
2019
Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre
Management of moderate‐to‐severe atopic dermatitis (AD) frequently requires treatment with systemic therapies. Dupilumab is the… 
Highly Cited
2019
Highly Cited
2019
Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
We report 10 cases of conjunctivitis in atopic dermatitis (AD) patients treated with dupilumab from November 2017 to November… 
Highly Cited
2019
Highly Cited
2019
Development or Exacerbation of Head and Neck Dermatitis in Patients Treated for Atopic Dermatitis With Dupilumab.
The efficacy and safety of dupilumab, a humanized monoclonal antibody targeting the α subunit of the interleukin (IL)-4 and IL-13… 
Highly Cited
2019
Highly Cited
2019
Psoriasis induced by dupilumab therapy
Dupilumab is a fully human monoclonal antibody that binds specifically to the shared alpha chain subunit of the interleukin (IL… 
Review
2018
Review
2018
Dupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials
Abstract Objective: We aimed to perform a meta-analysis evaluating the efficacy and safety of dupilumab in patients with… 
Review
2017
Review
2017
Role of Type 2 Innate Lymphoid Cells in Allergic Diseases
Purpose of ReviewThe adaptive immune response orchestrated by type 2 T helper (Th2) lymphocytes, strictly cooperates with the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)